Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 4Unknown 3Withdrawn 1Terminated 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 9Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Cyclophosphamide 9Epirubicin 6Docetaxel 6Fluorouracil 4Bevacizumab 4Trastuzumab 3Tamoxifen 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Thiotepa 2Paclitaxel 2Filgrastim 2Carboplatin 2pembrolizumab 1aldesleukin 1Vinorelbine 1Therapeutics 1Methotrexate 1Mesna 1Hypnosis 1High-Energy Shock Waves 1Goserelin 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Chemotherapy, Adjuvant 1Capecitabine 1CMF regimen 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Inflammatory Breast Neoplasms × Neoadjuvant Therapy × Clear all
NCT01641406 2012-07-16

NACprotocol

Auxilio Mutuo Cancer Center

Phase 2 Unknown
60 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
94 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡